>A0A0E1S5W1 Fimbrial usher protein (EC 3.2.1.33)
MRIRHSFLCVFMLAAGSHARATEFNASFLSIDGRNDVDLSQFAQADYTLPGTYLLDVQVN
DVFFGLQSIEFVAHDDGQGARACVAPELVAQFGLKKSLVENLPRTMGGRCADLASLDGVT
IRYQKGEGRLKITIAQAALEFADASYLPPERWSDGVDGAMLDYRLLANANHAFGRGAQQN
NSVQAYGTIGANRGAWRFRGDYQAQTRAGGAVYAERAFRFNQLYAYRALPSIRSTLSFGE
IYVDSDIFSTFSMSGVAMKSDDRMLPPSMRGYAPLVTGVARTNAIVKVMQDSRVLYMTKV
SPGAFALSNLNTSVQGTLDVVVEEEDGTVQRFQVATASVPFLAREGQLRYKTAIGQPRTF
GGAGITPWFGFAEAAYGLPFDVTVYGGLIAASGYTSVAFGVGRDFGRFGALSADVTHARA
TLWWNGRTKRGNSYRINYSKHVDALDADVRFFGYRFSERDYTNFQQFSGDPTASGLANGK
QRYSAMLSKRFGDTSTYFSYDQTTYWARPSDRRIGVTLTRAFSLGALKSVNLGFSAFRTQ
GAGGGGNQVSLTATLPLGERQTLTSSVSAGEGGTSVNAGYLYDGANGRTYQLYGGTTDGR
ASANASLRQRTPSYQLTAQASTVANAYASASLEVDGSFVATRYGVTAHANGNAGDTRLLV
STDGVPGVPLSGSYARTNARGYAVIDGVSPYNVYDATVSVEKLGLDTDVTNPIQRTVLTD
GAIGYIRFNAARGRNVFVTLTGDGGAPVPFGASVQDAATGKELGIVGEAGAAYLTQVQPR
AKLVVRAGAKTICTPAALPDTLQLDGTPAPVACEAAAQHASR
>A0A0E1W9W4 Fimbrial usher protein (EC 3.2.1.33)
MRIRHSFLCVFMLAAGSHARATEFNASFLSIDGRNDVDLSQFAQADYTLPGTYLLDVQVN
DVFFGLQPIEFVAHDDGQGARACVAPELVAQFGLKKSLVENLPRTMGGRCADLASLDGVT
IRYQKGEGRLKITIAQAALEFADASYLPPERWSDGVDGAMLDYRVLANANHAFGRGAQQN
NAVQAYGTIGANWGAWRFRGDYQAQTRAGGAVYAERAFRFNQLYAYRALPSIRSTLSFGE
IYVDSDIFSTFSMSGVAMKSDDRMLPPSMRGYAPLVTGVARTNAIVKVMQDSRVLYMTKV
SPGAFALSNLNTSVQGTLDVVVEEEDGTVQRFQVATAAVPFLAREGQLRYKTAIGQPRTF
GGAGITPWFGFAEAAYGLPFDVTVYGGLIAASGYTSVAFGVGRDFGRFGALSADVTHARA
TLWWNGRTKRGNSYRINYSKHVDALDADVRFFGYRFSERDYTNFQQFSGDPTASGLANGK
QRYSAMLSKRFGDTSTYFSYDQTTYWARPSDRRIGVTLTRAFSLGALKSVNLGFSAFRTQ
GAGGGGNQVSLTATLPLGERQTLTSSVSAGEGGTSVNAGYLYDGANGRTYQLYGGTTDGR
ASANASLRQRTPSYQLTAQASTVANAYASASLEVDGSFVATRYGVTAHANGNAGDTRLLV
STDGVPGVPLSGSYARTNARGYAVIDGVSPYNVYDATVSVEKLGLDTDVTNPIQRTVLTD
GAIGYIRFNAARGRNVFVTLTGDGGAPVPFGASVQDAATGKELGIVGEAGAAYLTQVQPR
AKLVVRAGAKTICTPAALPDTLQLDGTPAPVACEAAAQHASR
>F9YRQ5 Putative 4-alpha-glucanotransferase and amylo-alpha-1,6-glucosidase (EC 2.4.1.25) (EC 3.2.1.33)
MSYLTFKKKELINLEYSLDREFLGTNRGGGYSSSTLVFCNTRKYHGLLVVPLENFRGQNH
VLLSSLDETIIQHGRDFNFAVHQYPETYEPRGHKYIVDVSYEKAFTVIYQVGGVTLKKEI
LMVHNEPQVLVRYTLLEAHSPTKLRLNPLLAFRDIHSLSKVNDLANKNIEKIEGGIKTKL
YPDFPYLHLQLSQDTDFEYQPNWNCNIFYKKEKERGYDYTEDLLTLGYFELNIKKGESVV
FSASTEENNSKQLKQKFTRLINQRRERNSFEECLNYSATQFLIQKAGEIRVKEGYHWYNS
NTRDTFIALPGIALAENTQKTFDEVLTSVKKYFSNGLFEKTVSTHVAEPQYDADTSLWFF
WTIQQYEKYTKKTPKQLWKDFGELMRTILETYKNGRHKSIRMDNNGLIWSEDISRPLTWV
DAQFDGGAIVPRNGYVVEVNALWYNAVCYALALAEASKDKDFLKEWSDLPTMIAENFNQT
FWITDKKYLADYVNYAHQNRDVRPNQLITCALAYSPLDERSKKRVLDIVRQELLTPRGLR
SLSPKNKSYESVSIGNVYDRDRATFNGSVHPWFIGFYIEAHLKIYGKTYIPDAEAILADF
EEELSGHGVSTISAIYDGNPPFRSRGCISKARNVAEILRAKQLTMSYES
>A3NV04 Fimbrial usher protein (EC 3.2.1.33)
MFMLAAGSHARATEFNASFLSIDGRNDVDLSQFAQADYTLPGTYLLDVQVNDVFFGLQPI
EFVAHDDGQGARACVAPELVAQFGLKKSLVENLPRTMGGRCADLASLDGVTIRYQKGEGR
LKITIAQAALEFADASYLPPERWSDGVDGAMLDYRVLANANHAFGRGAQQNNAVQAYGTI
GANWGAWRFRGDYQAQTRAGGAVYAERAFRFNQLYAYRALPSIRSTLSFGEIYVDSDIFS
TFSMSGVAMKSDDRMLPPSMRGYAPLVTGVARTNAIVKVMQDSRVLYMTKVSPGAFALSN
LNTSVQGTLDVVVEEEDGTVQRFQVATAAVPFLAREGQLRYKTAIGQPRTFGGAGITPWF
GFAEAAYGLPFDVTVYGGLIAASGYTSVAFGVGRDFGRFGALSADVTHARATLWWNGRTK
RGNSYRINYSKHVDALDADVRFFGYRFSERDYTNFQQFSGDPTASGLANGKQRYSAMLSK
RFGDTSTYFSYDQTIYWARPSDRRIGVTLTRAFSLGALKSVNLGFSAFRTQGAGGGGNQV
SLTATLPLGERQTLTSSVSAGEGGTSVNAGYLYDGANGRTYQLYGGTTDGRASANASLRQ
RTPSYQLTAQASTVANAYASASLEVDGSFVATRYGVTAHANGNAGDTRLLVSTDGVPGVP
LSGSYARTNARGYAVIDGVSPYNVYDATVSVEKLGLDTDVTNPIQRTVLTDGAIGYIRFN
AARGRNVFVTLTGDGGAPVPFGASVQDAATGKELGIVGEAGAAYLTQVQPRAKLVVRAGA
KTICTPAALPDTLQLDGTPAPVACEAAAQHASR
>A3N9B1 Fimbrial usher protein (EC 3.2.1.33)
MFMLAAGSHARATEFNASFLSIDGRNDVDLSQFAQADYTLPGTYLLDVQVNDVFFGLQPI
EFVAHDGGQGARACVAPELVAQFGLKKSLVENLPRTMGGRCADLASLDGVTIRYQKGEGR
LKITIAQAALEFADASYLPPERWSDGVDGAMLDYRVLANANHAFGRGAQQNNAVQAYGTI
GANWGAWRFRGDYQAQTRAGGAVYAERAFRFNQLYAYRALPSIRSTLSFGEIYVDSDIFS
TFSMSGVAMKSDDRMLPPSMRGYAPLVTGVARTNAIVKVMQDSRVLYMTKVSPGAFALSN
LNTSVQGTLDVVVEEEDGTVQRFQVATAAVPFLAREGQLRYKTAIGQPRTFGGAGITPWF
GFAEAAYGLPFDVTVYGGLIAASGYTSVAFGVGRDFGRFGALSADVTHARATLWWSGRTK
RGNSYRINYSKHVDALDADVRFFGYRFSERDYTNFQQFSGDPTASGLANGKQRYSAMLSK
RFGDTSTYFSYDQTTYWARPSDRRIGVTLTRAFSLGALKSVNLGFSAFRTQGAGGGGNQV
SLTATLPLGERQTLTSSVSAGEGGTSVNAGYLYDGANGRTYQLYGGTTDGRASANASLRQ
RTPSYQLTAQASTVANAYASASLEVDGSFVATRYGVTAHANGNAGDTRLLVSTDGVPGVP
LSGSYARTNARGYAVIDGVSPYNVYDATVSVEKLGLDTDVTNPIQRTVLTDGAIGYIRFN
AARGRNVFVTLTGDGGAPVPFGASVQDAATGKELGIVGEAGAAYLTQVQPRAKLVVRAGA
KTICTPAALPDTLQLDGTPAPVACEAAAQHASR
>B1HIV6 Fimbrial usher protein (EC 3.2.1.33)
MFMLAAGSHARATEFNASFLSIDGRNDVDLSQFAQADYTLPGTYLLDVQVNDVFFGLQPI
EFVAHDDGQGARACVAPELVAQFGLKKSLVENLPRTMGGRCADLASLDGVTIRYQKGEGR
LKITIAQAALEFADASYLPPERWSDGVDGAMLDYRVLANANHAFGRGAQQNNAVQAYGTI
GANWGAWRFRGDYQAQTRAGGAVYAERAFRFNQLYAYRALPSIRSTLSFGEIYVDSDIFS
TFSMSGVAMKSDDRMLPPSMRGYAPLVTGVARTNAIVKVMQDSRVLYMTKVSPGAFALSN
LNTSVQGTLDVVVEEEDGTVQRFQVATASVPFLAREGQLRYKTAIGQPRTFGGAGITPWF
GFAEAAYGLPFDVTVYGGLIAASGYTSVAFGVGRDFGRFGALSADVTHARATLWWNGRTK
RGNSYRINYSKHVDALDADVRFFGYRFSERDYTNFQQFSGDPTASGLANGKQRYSAMLSK
RFGDTSTYFSYDQTTYWARPSDRRIGVTLTRAFSLGALKSVNLGFSAFRTQGAGGGGNQV
SLTATLPLGERQTLTSSVSAGEGGTSVNAGYLYDGANGRTYQLYGGTTDGRASANASLRQ
RTPSYQLTAQASTVANAYASASLEVDGSFVATRYGVTAHANGNAGDTRLLVSTDGVPGVP
LSGSYARTNARGYAVIDGVSPYNVYDATVSVEKLGLDTDVTNPIQRTVLTDGAIGYIRFN
AARGRNVFVTLTGDGGAPVPFGASVQDAATGKELGIVGEAGAAYLTQVQPRAKLVVRAGA
KTICTPAALPDTLQLDGTPAPVACEAAAQHASR
>A0A0B7INN9 Putative 4-alpha-glucanotransferase and amylo-alpha-1,6-glucosidase (EC 2.4.1.25) (EC 3.2.1.33)
MSYLTFKKKELINLEYSLDREFLGTNRGGGYSSSTLVFCNTRKYHGLLVVPLENFRGQNH
VLLSSLDETIIQHGRDFNFAVHQYPETYEPRGHKYIVDVSYEKAFTVIYQVGGVTLKKEI
LMVHNEPQVLVRYTLLEAHSPTKLRLNPLLAFRDIHSLSKVNDLANKNIEKIEGGIKTKL
YPDFPYLHLQLSQDTDFEYQPNWNCNIFYKKEKERGYDYTEDLLTLGYFELNIKKGESVV
FSASTEENNSKQLKQKFTRLINQRRERNSFEECLNYSATQFLIQKAGEIRVKEGYHWYNS
NTRDTFIALPGIALAENTQKTFDEVLTSVKKYFSNGLFEKTVSTHVAEPQYDADTSLWFF
WTIQQYEKYTKKTPKQLWKDFGELMRTILETYKNGQHKSIRMDNNGLIWSEDISRPLTWV
DAQFDGGAIVPRNGYVVEVNALWYNAVCYALALAEASKDKDFLKEWSDLPTMIAENFNQT
FWIADKKYLADYVNYAHQNRDVRPNQLIPCALAYSPLDERSKKRVLDIVRQELLTPRGLR
SLSPKNKSYESVSIGNVYDRDRATFNGSVHPWFIGFYIEAHLKIYGKTYIPDAEAILADF
EEELSGHGVSTISAIYDGNPPFRSRGCISKARNVAEILRAKQLTVSYEL
>A8EDV5 Fimbrial usher protein (EC 3.2.1.33)
MFMLAAGSHARATEFNASFLSIDGRNDVDLSQFAQADYTLPGTYLLDVQVNDVFFGLQPI
EFVAHDDGQGARACVAPELVAQFGLKKSLVENLPRTMGGRCADLASLDGVTIRYQKGEGR
LKITIAQAALEFADASYLPPERWSDGVDGAMLDYRVLANANHAFGRGAQQNNAVQAYGTI
GANWGAWRFRGDYQAQTRAGGAVYAERAFRFNQLYAYRALPSIRSTLSFGEIYVDSDIFS
TFSMSGVAMKSDDRMLPPSMRGYAPLVTGVARTNAIVKVMQDSRVLYMTKVSPGAFALSN
LNTSVQGTLDVVVEEEDGTVQRFQVATAAVPFLAREGQLRYKTAIGQPRTFGGAGITPWF
GFAEAAYGLPFDVTVYGGLIAASGYTSVAFGVGRDFGRFGALSADVTHARATLWWNGRTK
RGNSYRINYSKHVDALDADVRFFGYRFSERDYTNFQQFSGDPTASGLANGKQRYSAMLSK
RFGDTSTYFSYDQTTYWARPSDRRIGVTLTRAFSLGALKSVNLGFSAFRTQGAGGGGNQV
SLTATLPLGERQTLTSSVSAGEGGTSVNAGYLYDGANGRTYQLYGGTTDGRASANASLRQ
RTPSYQLTAQASTVANAYASASLEVDGSFVATRYGVTAHANGNAGDTRLLVSTDGVPGVP
LSGSYARTNARGYAVIDGVSPYNVYDATVSVEKLGLDTDVTNPIQRTVLTDGAIGYIRFN
AARGRNVFVTLTGDGGAPVPFGASVQDAATGKELGIVGEAGAAYLTQVQPRAKLVVRAGA
KTICTPAALPDTLQLDGTPAPVACEAAAQHASR
>A0A0B7HAX3 Putative 4-alpha-glucanotransferase and amylo-alpha-1,6-glucosidase (EC 2.4.1.25) (EC 3.2.1.33)
MSYLTFKKKELINLEYSLDREFLGTNRGGGYSSSTLVFCNTRKYHGLLVVPLENFRGQNH
VLLSSLDETIIQHGRDFNFAVHQYPETYEPRGHKYIVDVSYEKAFTVIYQVGGVTLKKEI
LMVHNEPQVLVRYTLLEAHSPTKLRLNPLLAFRDIHSLSKVNDLANKNIEKIEGGIKTKL
YPDFPYLHLQLSQDTDFEYQPNWNCNIFYKKEKERGYDYTEDLLTLGYFELNIKKGESVV
FSASTEENNSKQLKQKFTRLINQRRERNSFEECLNYSATQFLIQKAGEIRVKEGYHWYNS
NTRDTFIALPGIALAENTQKTFDEVLTSVKKYFSNGLFEKTVSTHVAERQYDADTSLWFF
WTIQQYEKYTKKTPKQLWKDFGELMRTILETYKNGQHKSIRMDNNGLIWSEDISRPLTWV
DAQFDGGAIVPRNGYVVEVNALWYNAVCYALALAEASKDKDFLKEWSDLPMMIAENFNQT
FWISDKKYLADYVNYAHQNRDVRPNQLIPCALAYSPLDERSKKRVLDIVRQELLTPRGLR
SLSPKNKSYESVSIGNVYDRDRATFNGSVHPWFIGFYIEAHLKIYGKTYIPDAEAILADF
EEELSGHGVSTISAIYDGNPPFRSRGCISKARNVAEILRAKQLTMNYES
>A0A0B7HXD7 Putative 4-alpha-glucanotransferase and amylo-alpha-1,6-glucosidase (EC 2.4.1.25) (EC 3.2.1.33)
MSYLTFKKKELINLEYSLDREFLGTNRGGGYSSSTLVFCNTRKYHGLLVVPLENFRGQNH
VLLSSLDETIIQHGRDFNFAVHQYPETYEPRGHKYIVDVSYEKAFTVIYQVGGVTLKKEI
LMVHNEPQVLVRYTLLEAHSPTKLRLNPLLAFRDIHSLSKVNDLANKNIEKIEGGIKTKL
YPDFPYLHLQLSQDTDFEYQPNWNCNIFYKKEKERGYDYTEDLLTLGYFELNIKKGESVV
FSASTEENNSKQLKQKFTRLINQRRERNSFEECLNYSATQFLIQKAGEIRVKEGYHWYNS
NTRDTFIALPGIALAENTQKTFDEVLTSVKKYFSNGLFEKTVSTHVAERQYDADTSLWFF
WTIQQYEKYTKKTPKQLWKDFGELMRTILETYKNGQHKSIRMDNNGLIWSEDISRPLTWV
DAQFDGGAIVPRNGYVVEVNALWYNAVCYALALAEASKDKDFLKEWSDLPMMIAENFNQT
FWISDKKYLADYVNYAHQNRDVRPNQLITCALAYSPLDERSKKRVLDIVRQELLTPRGLR
SLSPKNKSYESVSIGNVYDRDRATFNGSVHPWFIGFYIEAHLKIYGKTYIPDAEAILADF
EEELSGHGVSTISAIYDGNPPFRSRGCISKARNVAEILRAKQLTMNYES
>A0A0E1U0C6 Fimbrial usher protein (EC 3.2.1.33)
MFMLAAGSHARATEFNASFLSIDGRNDVDLSQFAQADYTLPGTYLLDVQVNDVFFGLQPI
EFVAHDDGQGARACVAPELVAQFGLKKSLVENLPRTMGGRCADLASLDGVTIRYQKGEGR
LKITIAQAALEFADASYLPPERWSDGVDGAMLDYRVLANANHAFGRGAQQNNSVQAYGTI
GANWGAWRFRGDYQAQTRAGGAVYAERAFRFNQLYAYRALPSIRSTLSFGEIYVDSDIFS
TFSMSGVAMKSDDRMLPPSMRGYAPLVTGVARTNAIVKVMQDSRVLYMTKVSPGAFALSN
LNTSVQGTLDVVVEEEDGTVQRFQVATASVPFLAREGQLRYKTAIGQPRTFGGAGITPWF
GFAEAAYGLPFDVTVYGGLIAASGYTSVAFGVGRDFGRFGALSADVTHARATLWWNGRTK
RGNSYRINYSKHVDALDADVRFFGYRFSERDYTNFQQFSGDPTASGLANGKQRYSAMLSK
RFGDTSTYFSYDQTTYWARPSDRRIGVTLTRAFSLGALKSVNLGFSAFRTQGAGGGGNQV
SLTATLPLGERQTLTSSVSAGEGGTSVNAGYLYDGANGRTYQLYGGTTDGRASANASLRQ
RTPSYQLTAQASTVANAYASASLEVDGSFVATRYGVTAHANGNAGDTRLLVSTDGVPGVP
LSGSYARTNARGYAVIDGVSPYNVYDATVSVEKLGLDTDVTNPIQRTVLTDGAIGYIRFN
AARGRNVFVTLTGDGGAPVPFGASVQDAATGKELGIVGEAGAAYLTQVQPRAKLVVRAGA
KTICTPAALPDTLQLDGTPAPVACEAAAQHASR
>A0A0B7I5Q4 Putative 4-alpha-glucanotransferase and amylo-alpha-1,6-glucosidase (EC 2.4.1.25) (EC 3.2.1.33)
MSYLTFKKKELINLEYSLDREFLGTNRGGGYSSSTLVFCNTRKYHGLLVVPLENFRGQNH
VLLSSLDETIIQHGRDFNFAVHQYPETYEPRGHKYIVDVSYEKAFTVIYQVGGVTLKKEI
LMVHNEPQVLVRYTLLEAHSPTKLRLNPLLAFRDIHSLSKVNDLANKNIEKIEGGIKTKL
YPDFPYLHLQLSQDTDFEYQPNWNCNIFYKKEKERGYDYTEDLLTLGYFELNIKKGESVV
FSASTEENNSKQLKQKFTRLINQRRERNSFEECLNYSATQFLIQKAGEIRVKEGYHWYNS
NTRDTFIALPGIALAENTQKTFDEVLTSVKKYFSNGLFEKTVSTHVAERQYDADTSLWFF
WTIQQYEKYTKKTPKQLWKDFGELMRTILETYKNGQHKSIRMDNNGLIWSEDISRPLTWV
DAQFDGGAIVPRNGYVVEVNALWYNAVCYAIALAEASKDKDFLKEWSDLPTMIAENFNQT
FWIADKKYLADYVNYAHQNRDVRPNQLIPCALAYSPLDERSKKRVLDIVRQELLTPRGLR
SLSPKNKSYESVSIGNVYDRDRATFNGSVHPWFIGFYIEAHLKIYGKTYIPDAEVILADF
EEELSGHGVSTISAIYDGNPPFRSRGCISKARNVAEILRAKQLTMNYES
>A0A0E1UKH8 Fimbrial usher protein (EC 3.2.1.33)
MFMLAAGSHARATEFNASFLSIDGRNDVDLSQFAQADYTLPGTYLLDVQVNDVFFGLQPI
EFVAHDDGQGARACVAPELVAQFGLKKSLVENLPRTMGGRCADLASLDGVTIRYQKGEGR
LKITIAQAALEFADASYLPPERWSDGVDGAMLDYRVLANANHAFGRGAQQNNAVQAYGTI
GANWGAWRFRGDYQAQTRAGGAVYAERAFRFNQLYAYRALPSIRSTLSFGEIYVDSDIFS
TFSMSGVAMKSDDRMLPPSMRGYAPLVTGVARTNAIVKVMQDSRVLYMTKVSPGAFALSN
LNTSVQGTLDVVVEEEDGTVQRFQVATAAVPFLAREGQLRYKTAIGQPRTFGGAGITPWF
GFAEAAYGLPFDVTVYGGLIAASGYTSVAFGVGRDFGRFGALSADVTHARATLWWNGRTK
RGNSYRINYSKHVDALDADVRFFGYRFSERDYTNFQQFSGDPTASGLANGKQRYSAMLSK
RFGDTSTYFSYDQTTYWARPSDRRIGVTLTRAFSLGALKSVNLGFSAFRTQGAGGGGNQV
SLTATLPLGERQTLTSSVSAGEGGTSVNAGYLYDGANGRTYQLYGGTTDGRASANASLRQ
RTPSYQLTAQASTVANAYASASLEVDGSFVATRYGVTAHANGNAGDTRLLVSTDGVPGVP
LSGSYARTNARGYAVIDGVSPYNVYDATVSVEKLGLDTDVTNPIQRTVLTDGAIGYIRFN
AARGRNVFVTLTGDGGAPVPFGASVQDAATGKELGIVGEAGAAYLTQVQPRAKLVVRAGA
KTICTPAALPDTLQLDGTPAPVACEAAAQHASR
>C0QFN6 Predicted transmembrane fusion protein, alpha-amylase domain and alpha-1,6-glucosidase domain (Glycogen debranching enzyme activity) (EC 2.4.1.19) (EC 3.2.1.33)
MNVSEMISQLPRPGTSRVMFCGDVLTFTLSIPSNVSGMAWIRTNLGRASIARNEIIDEVD
RNEIKLDEAWHDIQMTRQGPAVFAITLPLSETGHFRAKCFFWAEDSHAPVWPPGEDTIIN
VEPAGTCCANIVYNAFVRQFGPTRSQGQPLAQEEADCIQCLDKRGYAVIPSSGKFRDLSG
EIDFILTHLGCRAIHLLPIHPTPTTYGRMGRFGSPYAALNFTDVDPGLAEFDSSATPMEQ
FSALVDKIHSCAGYLILDIAINHTGWAASIHEKHPEWLVRNKEGEIAVPGAWGVLWADLT
RLDYSKKALWQYMADIFLLWCTRGVDGFRCDAGYMIPVPAWEYIVAKVKKEYPDTLFFLE
GLGGPLDATCDILSQANFNWAYSELFQNYDRKAVEAYLPTAISISEKFGHMIHFAETHDN
QRLAATSTRYAKMRTSLCALFSVCGGFGFANGVEWFATEKINVHESTCLNWGAKINQTDH
IRRLNLILKTHPAFADNVSLDLVQTGQGNYLVLCRRIAATDREIIVVANLDCKMSQTVLW
QARHQPEGVLFDLVTEQQVVAKLEGEILSVEVEPGRVMALTRDRQDIKRLQAADLKNDPI
PWRVVRQKQVACALKIVTTLAGYGDVSGLDLDYEADALVADPVAFIRSFNPDGNESRVVV
WEWNRDVRRQVMVPHGFFLMVVAPANFRAEIRTRTQGTVRTLEQNEALATRDGRFFAVFL
PFDTQGRVMEHTLKIRVLGAKGTQKAKAPLVFLPGSGTAFVSSTHTRKAIAKNPSLKLLG
VNHRGAMMRAFAWWGRLESRYDALLAANIQPDFPEERWMALTRFRIWATFQGYSRELTLD
CLESFTFSYGNRGLWRFRLPTSEGSHCPIEIALKMVDQTNAIEMDITRPAGSPRRNPLGD
DKQVTIIIRPDLEHRSFHETVKAWKGPENQWKSSISMVSGGFLFAPDPNHCTLGVKASDG
TFVWEPEWQYMVHRSLDAERGLDPDSDLFSPGYFIANLGGRDTIRISARVTCGKGPERDD
ILTGSDGPDTEFVRGWPLPEALTKSLDAFLVDRAKDRSVIAGYPWFLDWGRDSLIFSRAL
IQGERLVDAKKILRLFGRFEANGSLPNMISGNDARNRETSDAPLWFIAAAREVVEKEGGA
LLDQTLGGRTFKEILVSIGDAYVRGTQTGIAMDPETALVFSPSHFTWMDTNFPAGTPREG
YPIEIQALWAYSLEFLAKIDPNGTQAWARLADQVKDSIKTLFFMESRGYFSDCLHTRGKA
PAGSAVVDDALRPNQLFLISLGVIRDKDLCIPALEHCMELLVPGAIRTLDDSPVDLPLVI
EGPTGPLNDPHRPYWGHYMGDEDTRRKPAYHNGTAWTWVFPVFCEAWAETFGSKGAMTGI
SWLTSSVKLMEQGVAGFVPEIVDGDAPHAPRGCDAQAWGASELYRVWHKLSLRS
>A0A0B7HBY4 Putative 4-alpha-glucanotransferase and amylo-alpha-1,6-glucosidase (EC 2.4.1.25) (EC 3.2.1.33)
MSYLTFKKKELINLEYSLDREFLGTNRGGGYSSSTLVFCNTRKYHGLLVVPLENFRGQNH
VLLSSLDETIIQHGRDFNFAVHQYPETYEPRGHKYIVDVSYEKAFTVIYQVGGVTLKKEI
LMVHNEPQVLVRYTLLEAHSPTKLRLNPLLAFRDIHSLSKVNDLANKNIEKIEGGIKTKL
YPDFPYLHLQLSQDTDFEYQPNWNCNIFYKKEKERGYDYTEDLLTLGYFELNIKKGESVV
FSASTEENNSKQLKQKFTRLINQRRERNSFEECLNYSATQFLIQKAGEIRVKEGYHWYNS
NTRDTFIALPGIALAENTQKTFDEVLTSVKKYFSNGLFEKTVSTHVAERQYDADTSLWFF
WTIQQYEKYTKKTPKQLWKDFGELMRTILETYKNGQHKSIRMDNNGLIWSEDISRPLTWV
DAQFDGGAIVPRNGYVVEVNALWYNAVCYALVLAEASKDKDFLKEWSDLPTMIAENFNQT
FWIADKKYLADYVNYAHQNRDVRPNQLIPCALAYSPLDERSKKRVLDIVRQELLTPRGLR
SLSPKNKSYENVSIGNVYDRDRATFNGSVHPWFIGFYIEAHLKIYGKIYIPDAEAILADF
EEELSGHGVSTISAIYDGNPPFRSRGCISKARNVAEILRAKQLTMNYEL
>A0A0B7HGZ2 Putative 4-alpha-glucanotransferase and amylo-alpha-1,6-glucosidase (EC 2.4.1.25) (EC 3.2.1.33)
MSYLTFKKKELINLEYSLDREFLGTNRGGGYSSSTLVFCNTRKYHGLLVVPLENFRGQNH
ILLSSLDETIIQHGRDFNFAVHQYPETYEPRGHKYIVDVSYEKAFTVIYQVGGVTLKKEI
LMVHNEPQVLVRYTLLEAHSPTKLRLNPLLAFRDIHSLSKVNDLANKNIEKIEGGIKTKL
YPDFPYLHLQLSQDTDFEYQPNWNCNIFYKKEKERGYDYTEDLLTLGYFELNIKKGESVV
FSASTEENNSKQLKQKFTRLINQRRERNSFEECLNYSATQFLIQKAGEIRVKEGYHWYNS
NTRDTFIALPGIALAENTQKTFDEVLTSVKKYFSNGLFEKTVSTHVAEPQYDADTSLWFF
WTIQQYEKYTKKTPKQLWKEFGEVMRTILETYKNGQHKSIRMDNNGLIWSEDISRPLTWV
DAQFDGGAIVPRNGYVVEVNALWYNAVCYALVLAEASKDKDFLKEWSDLPTMIAENFNQT
FWIADKKYLADYVNYAHQNRDVRPNQLIPCALAYSPLDERSKKRVLDIVRQELLTPRGLR
SLSPKNKSYESVSIGNVYDRDRATFNGSVHPWFIGFYIEAHLKIYGKTYIPDAEAILADF
EEELSGHGVSTISAIYDGNPPFRSRGCISKARNVAEILRAKQLTMSYEL
>S0G2Z0 Putative transmembrane fusion protein (EC 2.4.1.19) (EC 3.2.1.33)
MISVAQMPLPGTSRVLFRGDCLRFTLTLNKKASGNAWVRTNLGTAAIARQEIIDRVEKNE
IKLDEGWYDIQMTRQDEVTFTLLLPLHQTGYFQAKCFFMPENQTVPIWPEGDNCILNVEP
AGTCCANIIYNAFVRQFGPSKNAPGPGLERSLVPLMETLDASGFTVIPESGKFRDLRDQI
GFIFSALGCRALHLLPIHPTPTTYARMGRFGSPYAALNFTDVDPALARFDPAATPLEQFM
ELVDAVHYHNGYLILDIAINHTGWAAAIHETHPEWLVRGEDGQIKAPGAWGVVWADLTKL
DYSHTDLWQYMAEIFLLWCHRGVDGFRCDAGYMVPIDAWEYMVAKVRQEYPDTLFLLEGL
GGPLKTTQAILGRGNFNWAYSELFQHYTREEIAEYLPFAVDISDTCGHMIHYAETHDNNR
LASVSSTYAKMRTALCALFSVCGGFGFANGMEWFAKEKINVHESPGLNWGAKDNQVDFIF
RLNWILKNHPTFFHTTRLTLIQKNETQALALLRSHPETGKTLLVLVNLDCEEPSPVFWHR
SDVGSDQNEWMDLLTETRVSLLQDGPVAGITLAPGEAMALTPDPGDVQALAADLLRDEQA
PAPVPNQVLDQKFRAGVLAVKTALDGYTDVSGLDLNHAARHLSEDPMEFIRSFFPDTLES
RVIPFDVTQDLKRQVMVPPGFFLLVKSPVGFRAEILDARDTDRRSLGYEEGLPLKTGGFF
ALFMPKTFRKLHKPCRLNLRLFHPDKIQKASAFLLYLASFDTLNLQTTFTRRKIAGDPGL
TLLAATRTGGMMRAAGDWGQLHSRYDTLLGANLNPDMPENRWMTLARCRIWAIFQGYSRE
LAKDCLQNFTFSYDNAGRWRFHVPTSEGKYYVLELTLMLSPHTNQVRLSITRPGTKNNRS
RILPDDAPVTLIIRPDMEDRGFHDTIKAFTGPETDWPARVRSRDTGVDFSLSNGHTLSMD
IQPPGRFVPEPEWQYMVHRPLEATRGLDPASDLFSPGYFSFECIGGHTAELMTRVDHGQR
FEPDAWPIPAFESGLTMEQALVRALDAFLVDRGQDKSVIAGYPWFLDWGRDSLIFCRSLV
ELGRLSEARAILHLFGRFERNGTLPNMICGQDAANIETSDAPLWFFACCRDILEKTKDSG
FLDQDLGKRTLRQVLLDMAHSLETGTPTGVKMDPKTRLLYSPSHFTWMDTNFPAGSPRQG
YPVEIQALWHNALMFLEKIDPGGEWKQKADQVKQSVETWFWNETAGYFSDCLHGNGPAAK
AVPDDALRPNQLLLITLGVIPSGEKARKTVETCLELLVPGGIRSLADRKVAVPLPVVHNK
KLVNDPDHPYAGVYQGDEDTNRKPAYHNGTAWTWPFPVFCEAWAKVFGQNSHAAGLAWLG
SMKHLMRTGAAGYIPEILDGDFPHTPRGCDAQAWGVSEAARVVHKLSARRP
>A0A0B7IJY9 Putative 4-alpha-glucanotransferase and amylo-alpha-1,6-glucosidase (EC 2.4.1.25) (EC 3.2.1.33)
MSYLTFKKKELINLEYSLDREFLGTNRGGGYSSSTLVFCNTRKYHGLLVVPLENFRGQNH
VLLSSLDETIIQHGRDFNFAVHQYPETYEPRGHKYIVDVSYEKAFTVIYQVGGVTLKKEI
LMVHNEPQVLVRYTLLEAHSPTKLRLNPLLAFRDIHSLSKVNDLANKNIEKIEGGIKTKL
YPDFPYLHLQLSQDADFEHQPNWNCNIFYKKEKERGYDYTEDLLTLGYFELNIKKGESVV
FSASTEENNSKQLKQKFTRLINQRRERNSFEECLNYSATQFLIQKAGEIRVKEGYHWYNS
NTRDTFIALPGIALAENTQKDVR
>A0A0B7IJZ3 Putative 4-alpha-glucanotransferase and amylo-alpha-1,6-glucosidase (EC 2.4.1.25) (EC 3.2.1.33)
MRYLHQLKKYFSNGLFEKTISTHVIEPQYDADTSLWFFWTIQQYEKYTKKTPKQLWKEFG
ELMRTILETYKNGRHKSIRMDNNGLIWSEDISRPLTWVDAQFDDGAIVPRNGYVVEVNAL
WYNAVCYALALAEASKDKDFLKEWSDLPMMIAENFNQTFWIADKKYLADYVNYAHQNRDV
RPNQLITCALAYSPLDERSKKRVLDIVRQELLTPRGLRSLSPKNKSYESVSIGNVYDRDR
ATFNGSVHPWFIGFLHRSSFKNLRKKPISLMQKQF
>Q88FN4 Glycogen debranching enzyme (EC 3.2.1.33)
MSPRTPKKTRSVAPSRIREGMPFPLGATWDGLGVNFALFSANATKVELCLFDSTGEQELE
RIELPEYTDEIYHGYLPDAHPGLVYGYRVYGPYEPENGHRFNPNKLLIDPYAKQLVGSLK
WSEALFGYTIGHPDGDLSFDERDSAPFVPKCKVIDPAFTWGRDQRVQIPWERTIIYEAHA
RGISMRHPAVPEELRGTFAGLANDELLKHIKDLGVSSIELLPIHAFVNDQHLLDKGLNNY
WGYNSIAFFAPHPRYLASGKIAEFKEMVAHLHDAGLEVILDVVYNHTAEGNERGPTLSMR
GIDNASYYRLMPDDKRYYINDSGTGNTLDLSHPCVLQLVTDSLRYWAGEMHVDGFRFDLA
TILGRYHDGYSERHGFLVACRQDPMLSQVKLIAEPWDCGPGGYQVGNFAPGWAEWNDRFR
DTARAFWKGDEGQLADFAARLTASGDMFNNRGRRPYSSVNFITAHDGFTLRDLVSYNHKH
NEDNDENNQDGTDNNLSWNCGVEGPTDDPAINALRMRQMRNYFATLLLAQGTPMIVAGDE
FSRTQHGNNNAYCQDSEIGWVNWDLDEEGQELLAFVKRLTRLRLAYPVLRRSRFLVGDYN
EAIGVKDVTWLAPDGSEMSVEQWEDPHGRCLGMLIDGRAQVSGIARPGAEATVLLIVNAH
HDIVPFKLPAVPEGDYWSCLVDTDRPELRKGQHLQFDSTFEVKGRSMLLMVLQYDEE
